UNITED NATIONS, Dec 1, 2008 (AFP) - Timely screenings can save the lives of newborns at risk of contracting HIV, according to a report released Monday by four UN agencies to mark World AIDS Day.
"Early diagnosis and treatment can significantly improve the prospects for survival of newborn babies exposed to HIV," said the report published by the United Nations Children's Fund (UNICEF), the World Health Organization (WHO), UNAIDS and the United Nations Population Fund (UNFPA).
"Without appropriate treatment, half of children with HIV will die from an HIV-related cause by their second birthday," warned UNICEF Executive Director Ann Veneman.
"Survival rates are up to 75 percent higher for HIV-positive newborns who are diagnosed and begin treatment within their first 12 weeks."
Outgoing UNAIDS Executive Director Peter Piot remained optimistic about the mother-to-child HIV transmission prevention, which he called a "human right."
"We are seeing good progress in many countries, especially in parts of Africa, but we need to significantly scale up HIV testing and treatment for pregnant women," he said.
But in 2007, less than 10 percent of newborns with HIV-positive mothers were tested for the virus, the report noted, also forecasting progress in some of the most affected countries where early screening will increase, including South Africa, Kenya, Malawi, Mozambique, Rwanda, Swaziland and Zambia.
WHO Director-General Margaret Chan stressed the "need to focus on strengthening our healthcare systems to ensure that all mothers and children receive treatment as early as possible."
081201
AF081212
Copyright ©AFP 2008. All Rights Reserved. AFP articles contained on the AEGiS web site may not be reproduced, distributed, transmitted, displayed, published or broadcast without AFP's prior written permission. You may make one copy of each article for your personal, non-commercial use only; more copies would require AFP's prior written permission obtained from the owners of any trademarks or copyrighted materials whose marks and materials are included in AFP photos or materials. Therefore you will be solely responsible for obtaining any and all necessary releases from whatever individuals and/or entities necessary for any uses of AFP stories, photos or graphics. http://www.afp.com/
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. This article first appeared in 2008. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2008. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.